ANAVEX LIFE SCIENCES CORP. (AVXL): Nasdaq/NYSE listing notice — Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026

ANAVEX LIFE SCIENCES CORP.

Nasdaq notice received May 20, 2026 due to late Form 10-Q for quarter ended March 31, 2026.
Company must submit a compliance plan by July 20, 2026 to regain listing compliance.
If plan is accepted, Nasdaq may grant an exception until November 16, 2026 to file.
No immediate effect on AVXL listing; stock continues trading on Nasdaq Global Select.
Anavex states it is working to complete and file the 10-Q and submit the compliance plan.

item 3.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

ANAVEX LIFE SCIENCES CORP. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

May 20, 2026, Anavex Life Sciences Corp. (the “Company”) received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ANAVEX LIFE SCIENCES CORP. filing history →

Source: SEC EDGAR

accession 0001731122-26-000781

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.